1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine

Star0

DB08471ExperimentalSmall molecule

1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine: Overview.

Formula / weight: C₁₇H₁₇N₃O₂S₂ · 359.466 g/mol (avg)

Resolves to

Compound

ChEMBLCHEMBL1235660PubChem1453694

Structure

InChIKeySJEVDMFUHCVNPM-UHFFFAOYSA-NSMILESO=C(CC1=CC=CS1)N1CCC(CC1)C1=NC(=NO1)C1=CC=CS1

Targets

P9WMC1ethR

What you can answer from here — as of April 02, 2025

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

1+ReferenceStructured and connected to the statements they support

Which drugs share a target with 1-(thiophen-2-ylacetyl)-4-(3-thiophen-2-yl-1,2,4-oxadiazol-5-yl)piperidine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account